Skip to main content
. Author manuscript; available in PMC: 2022 Jul 6.
Published in final edited form as: Stat Biopharm Res. 2021 Jul 6;13(3):260–269. doi: 10.1080/19466315.2021.1927824

Table 5.

Descriptive statistics for the non-ischemic subgroup in the HF-ACTION study.

Exericise training Usual care
N 220 231
Median follow-up 32 months 31 months
Death rate 0.036 per year 0.064 per year
Hospitalization rate 0.234 per year 0.274 per year